Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more. Contact Us We want to hear from you and engage in meaningful discussions. However, please note that we are not equipped to provide customer, candidate, or technical support through this platform. If you require assistance from those teams, please find their contact information here: https://www.edwards.com/aboutus/contactus If you’re a patient in need of medical advice, please contact your healthcare provider directly. We reserve the right to remove any comments that are off-topic, repetitive, or include hate speech, profanity, or offensive language. Additionally, we will not engage in discussions about competitor products, off-label use of Edwards products, or unsubstantiated/misleading claims that could cause harm. All Terms and Conditions of LinkedIn apply. For the Edwards Lifesciences privacy policy, visit https://www.edwards.com/legal/privacypolicy.
解锁市场时间线与信号动态
最近 90 天内有 424 个信号。
该公司进入各个市场的顺序 — 从最早到最新
Discover your next job opportunity in Pune, India
Join our growing IT teams in Pune, India
注册以查看完整信号动态
Edwards Lifesciences 的国际扩张与竞争对手的对比情况
Edwards Lifesciences你条形图显示所对比公司之间的相对规模。
5 项指标| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 Edwards Lifesciences你 | 38 | 0 | +18% | 399 | 32 |
快速扩张——最近 90 天新增 461 个职位，较上一周期增长 97%。 以 Sales 为主，集中在 法国。
Pune City, Maharashtra, India · 前天
Engineer II, AI/Machine Learning
Pune City, Maharashtra, India · 前天
Engineer II, AI/Machine Learning
Greater Besancon Area · 前天
Field Clinical Specialist, Mitral Therapies - Région Nord Est
在技术栈中检测到 59 项技术。
覆盖 40 个市场 的 4 个进行中的广告系列。
进行中
进行中
进行中最近 90 天获 3 次提及。
爱德华生命科学在香港成功完成首批三尖瓣反流患者治疗,使用PASCAL Precision系统,扩展2025年推出的二尖瓣应用范围。
Edwards Lifesciences公布COMMENCE试验10年结果,显示RESILIA组织结构性瓣膜退化免除率达97.9%,支持全球超过50万患者的长期耐用性。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Edwards Lifesciences 的业务、市场和增长信号的快速解答。
